Skip to main content

pantoprazole

Generic: PANTOPRAZOLE SODIUM·Brand: PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PROTONIX, PROTONIX IV, Protonix

pantoprazole: sourced relationships with 3 companies · 4 clinical trials tracked · 4 FDA decisions.

pantoprazole evidence translation

What we can confirm

4 FDA records · 4 tracked trials

What it means

More than one company relationship is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

What is verified about pantoprazole, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors
Dated Pipeline Records (3)
CompanyDated record stage
LANNETT CO INC (LCI)
Reported 2011-01-20 · Current development: unknownSource
Approved
DR REDDYS LABORATORIES LTD (RDY)
Reported 2011-01-19 · Current development: unknownSource
Approved
Teva Pharmaceutical Industries Limited (TEVA)
Reported 2007-08-02 · Current development: unknownSource
Approved
Clinical Trial Registry Records (4)

A Phase 1, Open-label, Randomized, Pharmacokinetic Study to Assess the Drug Interactions and Food Effect of Navlimetostat (BMS-986504) in Healthy Female Participants

NCT07800897Registry updated 2026-10-05·Phase 1·BMY
Recruiting

Primary endpoint: Maximum observed concentration (Cmax) of Navlimetostat

Interventionalopen80 targetStarted 2026-08Completion 2027-031 site · CanadaBristol-Myers Squibb

A Phase 1/2a, First-in-human, Randomized, Double-blinded, Placebo-controlled, Dose-finding Study in Healthy Volunteers and Participants With Sickle Cell Disease to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics, pH and Food Effect, and Preliminary Efficacy of BMS-986470

NCT06481306Registry updated 2026-08-18·Phase 1/Phase 2·BMY
Recruiting

Primary endpoint: Number of participants with adverse events (AEs)

InterventionalRandomizedquadruple224 targetStarted 2024-07Completion 2027-1132 sites · Canada, France, Italy, United Kingdom…Bristol-Myers Squibb

Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery

NCT06488001Registry updated 2025-05-21·Phase 2
Recruiting

Primary endpoint: Postoperative Nausea and Vomiting

InterventionalRandomizedtriple132 targetStarted 2022-08Completion 2026-121 site · United StatesUnited States Naval Medical Center, Portsmouth

Open Randomised Controlled parallEl Groups Study of Gastroprotective Efficacy of Rebamipide in Patients With Atrial Fibrillation and Moderate-to-high Risk of Thromboembolic Events, Who Are Treated With Direct Oral Anticoagulants (REGATA)

NCT07354230Registry updated 2026-01-21·Phase 4
Completed

Primary endpoint: Composite endpoint

InterventionalRandomizedopen210 enrolledStarted 2022-01Completion 2024-091 site · RussiaPirogov Russian National Research Medical University
FDA Decisions4 records
Approval(LCI)FDA ↗
ANDA078281OralTablet, Delayed Release
Approval(RDY)FDA ↗
ANDA077619OralTablet, Delayed Release
Tentative Approval(TEVA)FDA ↗
NDA022226Type 5 - New Formulation or New ManufacturerStandardOtherInjectable
ANDA077056OralTablet, Delayed Release

Frequently asked questions

Which companies have sourced relationships with pantoprazole?

pantoprazole has dated SEC/FDA relationship records for LANNETT CO INC, DR REDDYS LABORATORIES LTD, Teva Pharmaceutical Industries Limited.

How many clinical trials involve pantoprazole?

BioSniper tracks 4 clinical trials involving pantoprazole.

What is pantoprazole's latest FDA decision?

The most recent tracked FDA decision for pantoprazole is Approval, dated January 20, 2011.